In a mouse model of lung fibrosis, Lactobacillus supplementation significantly downregulated collagen 1 A production, inactivated the IL-17A and TGF-β1 signalling pathways, and alleviated bleomycin-stimulated lung fibrosis [77]. Here, IL17A is linked to pulmonary fibrosis.